Logo image of JBGS

JBG SMITH PROPERTIES (JBGS) Stock Fundamental Analysis

NYSE:JBGS - New York Stock Exchange, Inc. - US46590V1008 - REIT - Currency: USD

14.92  0 (0%)

After market: 14.67 -0.25 (-1.68%)

Fundamental Rating

1

Taking everything into account, JBGS scores 1 out of 10 in our fundamental rating. JBGS was compared to 129 industry peers in the Diversified REITs industry. JBGS may be in some trouble as it scores bad on both profitability and health. JBGS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JBGS had negative earnings in the past year.
In the past year JBGS had a positive cash flow from operations.
JBGS had negative earnings in 4 of the past 5 years.
Of the past 5 years JBGS 4 years had a positive operating cash flow.
JBGS Yearly Net Income VS EBIT VS OCF VS FCFJBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -2.29%, JBGS is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
The Return On Equity of JBGS (-6.29%) is worse than 73.81% of its industry peers.
JBGS has a worse Return On Invested Capital (0.22%) than 89.68% of its industry peers.
Industry RankSector Rank
ROA -2.29%
ROE -6.29%
ROIC 0.22%
ROA(3y)-0.45%
ROA(5y)-0.28%
ROE(3y)-1.13%
ROE(5y)-0.71%
ROIC(3y)N/A
ROIC(5y)N/A
JBGS Yearly ROA, ROE, ROICJBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2

1.3 Margins

JBGS has a worse Operating Margin (2.52%) than 90.48% of its industry peers.
JBGS's Operating Margin has been stable in the last couple of years.
JBGS has a worse Gross Margin (50.72%) than 79.37% of its industry peers.
JBGS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.52%
PM (TTM) N/A
GM 50.72%
OM growth 3YN/A
OM growth 5Y-1.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.85%
GM growth 5Y-0.05%
JBGS Yearly Profit, Operating, Gross MarginsJBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JBGS is destroying value.
There is no outstanding debt for JBGS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JBGS Yearly Shares OutstandingJBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
JBGS Yearly Total Debt VS Total AssetsJBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that JBGS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.15, JBGS is not doing good in the industry: 74.60% of the companies in the same industry are doing better.
JBGS has a Debt/Equity ratio of 1.39. This is a high value indicating a heavy dependency on external financing.
JBGS has a Debt to Equity ratio (1.39) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACC0.04
WACC6.06%
JBGS Yearly LT Debt VS Equity VS FCFJBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

JBGS has a Current Ratio of 2.24. This indicates that JBGS is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.24, JBGS is doing good in the industry, outperforming 77.78% of the companies in the same industry.
A Quick Ratio of 2.24 indicates that JBGS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.24, JBGS is doing good in the industry, outperforming 79.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
JBGS Yearly Current Assets VS Current LiabilitesJBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.69% over the past year.
EPS 1Y (TTM)4.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-26.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-174.23%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBGS Yearly Revenue VS EstimatesJBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
JBGS Yearly EPS VS EstimatesJBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

JBGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JBGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBGS Price Earnings VS Forward Price EarningsJBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBGS indicates a slightly more expensive valuation: JBGS is more expensive than 60.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.86
JBGS Per share dataJBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.80%, JBGS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 18.48, JBGS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.29, JBGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.8%

5.2 History

The dividend of JBGS has a limited annual growth rate of 0.08%.
JBGS has been paying a dividend for over 5 years, so it has already some track record.
The dividend of JBGS decreased recently.
Dividend Growth(5Y)0.08%
Div Incr Years1
Div Non Decr Years1
JBGS Yearly Dividends per shareJBGS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

JBGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-57.98%
EPS Next 2YN/A
EPS Next 3YN/A
JBGS Yearly Income VS Free CF VS DividendJBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M -400M

JBG SMITH PROPERTIES

NYSE:JBGS (2/21/2025, 8:04:00 PM)

After market: 14.67 -0.25 (-1.68%)

14.92

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)04-28 2025-04-28
Inst Owners98.83%
Inst Owner Change1.62%
Ins Owners0.05%
Ins Owner Change-1.61%
Market Cap1.26B
Analysts42.5
Price Target15.81 (5.97%)
Short Float %8.55%
Short Ratio12.99
Dividend
Industry RankSector Rank
Dividend Yield 4.8%
Yearly Dividend0.9
Dividend Growth(5Y)0.08%
DP-57.98%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.9%
Min EPS beat(2)10.36%
Max EPS beat(2)35.44%
EPS beat(4)3
Avg EPS beat(4)5.49%
Min EPS beat(4)-71.57%
Max EPS beat(4)47.71%
EPS beat(8)5
Avg EPS beat(8)11.02%
EPS beat(12)7
Avg EPS beat(12)98%
EPS beat(16)10
Avg EPS beat(16)80.83%
Revenue beat(2)0
Avg Revenue beat(2)-9.35%
Min Revenue beat(2)-17.51%
Max Revenue beat(2)-1.2%
Revenue beat(4)1
Avg Revenue beat(4)-4.36%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)19.87%
Revenue beat(8)1
Avg Revenue beat(8)-7.52%
Revenue beat(12)1
Avg Revenue beat(12)-7.36%
Revenue beat(16)3
Avg Revenue beat(16)-2.37%
PT rev (1m)0%
PT rev (3m)-11.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-7.51%
Revenue NQ rev (3m)-7.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.23
P/FCF N/A
P/OCF 8.1
P/B 0.67
P/tB 0.69
EV/EBITDA 15.86
EPS(TTM)-0.61
EYN/A
EPS(NY)-1.67
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)1.84
OCFY12.35%
SpS6.68
BVpS22.28
TBVpS21.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.29%
ROE -6.29%
ROCE 0.28%
ROIC 0.22%
ROICexc 0.23%
ROICexgc 0.23%
OM 2.52%
PM (TTM) N/A
GM 50.72%
FCFM N/A
ROA(3y)-0.45%
ROA(5y)-0.28%
ROE(3y)-1.13%
ROE(5y)-0.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.94%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.95%
OM growth 3YN/A
OM growth 5Y-1.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.85%
GM growth 5Y-0.05%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Debt/EBITDA 11.11
Cap/Depr 119.11%
Cap/Sales 46.88%
Interest Coverage 0.13
Cash Conversion 65.89%
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 0.15
F-Score5
WACC6.06%
ROIC/WACC0.04
Cap/Depr(3y)167.49%
Cap/Depr(5y)193.72%
Cap/Sales(3y)61.11%
Cap/Sales(5y)67.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y-174.23%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-26.53%
Revenue Next Year-1.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.92%
EBIT growth 3YN/A
EBIT growth 5Y-2.38%
EBIT Next Year507.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.6%
OCF growth 3Y2.76%
OCF growth 5Y-0.52%